Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00183391 · ClinicalTrials.gov registry record · Phase 4
Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children
A Phase 4 study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 4
- Development phase
- 232
- Enrollment target
NCT00183391 is a Phase 4 study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 232 participants.
The verdict
NCT00183391, a Phase 4 study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 232 participants
- Enrollment target
Study Summary
This study will determine the effectiveness of stimulant and nonstimulant medication in treating the symptoms of attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Interventions
- DRUG Methylphenidate
- DRUG Atomoxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2005-07 |
| Est. Completion | 2011-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00183391
The ClinicalTrials.gov registry entry for NCT00183391 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 232 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Methylphenidate is the first listed.
NCT00183391 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00183391 about?
NCT00183391 is a clinical study titled "Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children". This study will determine the effectiveness of stimulant and nonstimulant medication in treating the symptoms of attention deficit hyperactivity disorder (ADHD) in children and adolescents.
What is the current status of trial NCT00183391?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 232 participants. The study started on 2005-07. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00183391?
The interventions under investigation include: Methylphenidate (DRUG), Atomoxetine (DRUG).
Who is sponsoring clinical trial NCT00183391?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.